Clopidogrel resistance: a new chapter in a fast-moving story
about
Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirinSuspected clopidogrel resistance in a patient with acute stent thrombosisClopidogrel resistance: myth or reality?Antiplatelet Therapy of Cilostazol or Sarpogrelate with Aspirin and Clopidogrel after Percutaneous Coronary Intervention: A Retrospective Cohort Study Using the Korean National Health Insurance Claim DatabaseTocotrienols-induced inhibition of platelet thrombus formation and platelet aggregation in stenosed canine coronary arteries.P2Y12 or P2Y1 inhibitors reduce platelet deposition in a microfluidic model of thrombosis while apyrase lacks efficacy under flow conditions.Newer pharmacotherapy in patients undergoing percutaneous coronary interventions: a guide for pharmacists and other health care professionals.Clopidogrel resistance--the cardiologist's perspective.Diabetes mellitus: a prothrombotic state implications for outcomes after coronary revascularizationBalancing potency of platelet inhibition with bleeding risk in the early treatment of acute coronary syndrome.Polymorphisms of MDR1, CYP2C19 and P2Y12 genes in Indian population: effects on clopidogrel response.Platelet reactivity and nonresponse to dual antiplatelet therapy: a review.Adoption of prasugrel into routine practice: rationale and design of the Rijnmond Collective Cardiology Research (CCR) study in percutaneous coronary intervention for acute coronary syndromes.Contemporary treatment of unstable angina and non-ST-segment-elevation myocardial infarction (part 2).Resistance to aspirin and clopidogrel therapy.Antiplatelet options for secondary prevention in acute coronary syndromes.Platelet adenosine diphosphate receptor antagonists: ticlopidine to ticagrelor-a long continuing journey.P2Y12 receptor: platelet thrombus formation and medical interventions.Proton pump inhibitors and clopidogrel: an association to avoid?Proteomic signatures of antiplatelet drugs: new approaches to exploring drug effects.A point-of-care assay to measure platelet aggregation in patients taking clopidogrel.Clopidogrel resistance: fact and fiction.Effects of Dual-Dose Clopidogrel, Clopidogrel Combined with Tongxinluo Capsule, and Ticagrelor on Patients with Coronary Heart Disease and CYP2C19*2 Gene Mutation After Percutaneous Coronary Interventions (PCI).Oral antiplatelet therapy and platelet inhibition: An experience from a tertiary care center.The significance of clopidogrel low-responsiveness on stent thrombosis and cardiac death assessed by the verifynow p(2)y(12) assay in patients with acute coronary syndrome within 6 months after drug-eluting stent implantation.Pharmacokinetics and platelet aggregation inhibitory effects of a novel intravenous formulation of clopidogrel in humans.Adding clopidogrel to aspirin improves outcome in ST-elevation myocardial infarction patients receiving fibrinolytic therapy.Hypertension as a risk factor for aspirin and clopidogrel resistance in patients with stable coronary artery disease.Sequential ADP-stimulated light transmission and multiple electrode aggregometry in patients taking aspirin and clopidogrel after non ST-elevation myocardial infarction.Platelet function profile post-clopidogrel therapy in patients with type 2 diabetes undergoing coronary stent implantation.Association of thrombelastographic parameters with post-stenting ischemic events.Antiplatelet and antithrombotic treatment for secondary prevention in ischaemic heart disease.Clopidogrel anti-platelet effect: an evaluation by optical aggregometry, impedance aggregometry, and the platelet function analyzer (PFA-100).Clopidogrel poor responders: an objective definition based on Bayesian classification.Clinical effect of Maixuekang Capsule (脉血康胶囊) on long-term prognosis in patients with acute coronary syndrome after percutaneous coronary intervention.Influence of cytochrome P450 polymorphisms on the antiplatelet effects of prasugrel in patients with non-cardioembolic stroke previously treated with clopidogrel
P2860
Q28195019-43E406BD-D4A4-454E-9113-89E33D6F54F8Q28196159-C92F8BAC-8B4D-4154-8726-B5C353B8B68FQ28218055-1D0D8B7B-D9F5-493D-8C88-037FA40B16BFQ28550517-99DF949E-E1BC-4982-91C5-36F946F299E4Q34987443-C70EBADD-35E1-4A37-B65C-C02F2D8C2866Q35636842-B90F6D28-FDC7-4ED7-9DAC-12C677B14789Q36634214-B869B1B3-17F3-4568-AE7E-BC1B05CBFD3CQ36819608-F1868670-F2E4-4865-896C-DFF4C47A5530Q37167506-FF955A20-54B6-4F63-9E5D-6572810BAA51Q37311337-FB826B4E-208E-45A4-994F-2FB81F68E231Q37388236-D0F0CE96-0100-4220-923C-C30D801BC1D6Q37618798-2C9FC67B-395E-4D55-A93E-44C42C2EEF2CQ37668119-091772AF-CEA7-4E2F-B882-6D1FCA5E806CQ37765146-8A65624D-B1A2-48E4-95D1-7E0207A673E0Q37807524-D0B4150B-5E17-4335-953A-1C628CB3AC7FQ37953465-CB6C7BEA-F667-4C11-8F97-67DBF7A203A2Q38008828-159AE422-0A00-4922-B92A-E87C6C13FE90Q38051192-CBAD2A97-9472-4F40-8E40-FF9E876C3B78Q38136990-6668A80A-C3A8-4BB8-B263-39A0BC4E0886Q38543311-38D04C13-988E-4126-9E9C-2A8FE2E1B021Q40329955-D7D02B7F-32FF-47E1-912B-87FFC4F931BEQ40347840-9808DD63-9093-4EE1-95DC-1EFBD9045420Q41383731-7BFD990A-6881-4911-9F41-8D93C5C776A0Q41571629-3EEABF2C-CDB1-477D-93C0-71B83BDD462DQ42114136-77FF3C24-FFA4-43E7-83C6-E94D9E6764C8Q42616979-3A8C08B6-55F6-4759-B8EA-95331B5AD3C6Q43266392-E98F34EA-2662-4FD5-8396-0B213C87C623Q44277034-920EAD85-F141-4760-B7FA-2419931C2639Q45381763-5219BCB2-E366-4EA8-880F-6753D0C763C5Q46358660-70E3D6B6-BEC4-4A06-A355-EF9FCA2062F8Q48146410-4D3101E1-0A71-43C3-A148-91C898FA1AD4Q48761201-82516A48-FF5E-47A8-8D2C-8B02ED22F9C0Q50676873-4F488AFE-6678-4187-A24A-57E3F52A257DQ51906913-4E82D5EB-F64F-4179-8E8D-4E44C6FB6523Q54440291-B9AD6658-55D3-4B86-B13D-DCAA55A5E2BFQ58800749-4D19FA2A-48AF-4321-B700-189AC5B80A92
P2860
Clopidogrel resistance: a new chapter in a fast-moving story
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Clopidogrel resistance: a new chapter in a fast-moving story
@ast
Clopidogrel resistance: a new chapter in a fast-moving story
@en
Clopidogrel resistance: a new chapter in a fast-moving story
@nl
type
label
Clopidogrel resistance: a new chapter in a fast-moving story
@ast
Clopidogrel resistance: a new chapter in a fast-moving story
@en
Clopidogrel resistance: a new chapter in a fast-moving story
@nl
prefLabel
Clopidogrel resistance: a new chapter in a fast-moving story
@ast
Clopidogrel resistance: a new chapter in a fast-moving story
@en
Clopidogrel resistance: a new chapter in a fast-moving story
@nl
P1433
P1476
Clopidogrel resistance: a new chapter in a fast-moving story
@en
P2093
Stephen D Wiviott
P304
P356
10.1161/01.CIR.0000134701.40946.30
P407
P577
2004-06-29T00:00:00Z